柳药集团
(603368)
| 流通市值：73.08亿 | | | 总市值：73.08亿 |
| 流通股本：3.97亿 | | | 总股本：3.97亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 15,758,036,706.01 | 10,300,787,773.83 | 5,316,977,105.59 | 21,182,454,178.26 |
| 营业收入 | 15,758,036,706.01 | 10,300,787,773.83 | 5,316,977,105.59 | 21,182,454,178.26 |
| 二、营业总成本 | 14,995,915,128.07 | 9,788,688,628.19 | 4,972,816,882.83 | 20,166,805,761.4 |
| 营业成本 | 14,043,758,870.81 | 9,160,530,355.09 | 4,677,904,464.93 | 18,774,823,172.61 |
| 税金及附加 | 45,941,277.59 | 31,337,897.47 | 12,871,325.65 | 63,599,669.94 |
| 销售费用 | 426,113,155.55 | 279,862,090.26 | 126,347,302.05 | 629,684,429.75 |
| 管理费用 | 290,888,480 | 189,665,875.88 | 95,492,260.09 | 423,863,503.09 |
| 研发费用 | 30,487,829.54 | 17,672,726.43 | 9,274,653.84 | 39,629,592.29 |
| 财务费用 | 158,725,514.58 | 109,619,683.06 | 50,926,876.27 | 235,205,393.72 |
| 其中:利息费用 | 149,363,017.64 | 101,707,104.51 | 48,303,306.57 | 214,545,031.94 |
| 其中:利息收入 | 21,326,245.51 | 15,057,036.52 | 8,529,694.34 | 36,925,040.37 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 248,767.82 | -2,388.31 | -1,262.62 | -95,285.99 |
| 资产处置收益 | 117,400.23 | 234,834.5 | 32,760.98 | 3,025,141.41 |
| 信用减值损失(新) | -25,208,309.88 | -19,135,048.42 | -39,623,890.99 | -32,119,064.88 |
| 其他收益 | 17,068,032 | 11,839,932.75 | 5,436,390.28 | 17,138,770.52 |
| 四、营业利润 | 754,347,468.11 | 505,036,476.16 | 310,004,220.41 | 1,003,597,977.92 |
| 加:营业外收入 | 3,102,507.86 | 2,277,367.99 | 1,018,001.03 | 14,587,726.06 |
| 减:营业外支出 | 8,937,737.34 | 8,273,901.04 | 479,612.07 | 15,049,521.14 |
| 五、利润总额 | 748,512,238.63 | 499,039,943.11 | 310,542,609.37 | 1,003,136,182.84 |
| 减:所得税费用 | 94,555,996.96 | 60,652,411.07 | 32,852,201.59 | 135,601,795.28 |
| 六、净利润 | 653,956,241.67 | 438,387,532.04 | 277,690,407.78 | 867,534,387.56 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 653,956,241.67 | 438,387,532.04 | 277,690,407.78 | 867,534,387.56 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 645,713,103.42 | 429,281,796.54 | 277,335,135.88 | 854,872,384 |
| 少数股东损益 | 8,243,138.25 | 9,105,735.5 | 355,271.9 | 12,662,003.56 |
| 扣除非经常损益后的净利润 | 633,529,512.28 | 421,955,479.09 | 272,427,291.93 | 837,121,583.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.63 | 1.08 | 0.7 | 2.21 |
| (二)稀释每股收益 | 1.63 | 1.08 | 0.7 | 2.21 |
| 九、综合收益总额 | 653,956,241.67 | 438,387,532.04 | 277,690,407.78 | 867,534,387.56 |
| 归属于母公司股东的综合收益总额 | 645,713,103.42 | 429,281,796.54 | 277,335,135.88 | 854,872,384 |
| 归属于少数股东的综合收益总额 | 8,243,138.25 | 9,105,735.5 | 355,271.9 | 12,662,003.56 |
| 公告日期 | 2025-10-30 | 2025-08-29 | 2025-04-29 | 2025-03-27 |
| 审计意见(境内) | | | | 标准无保留意见 |